熱門資訊> 正文

万达制药第二季度盈利预览

2025-07-30 23:04

Vanda Pharmaceuticals (NASDAQ:VNDA) is scheduled to announce Q2 earnings results on Thursday, July 31st, before market open.
The consensus EPS Estimate is -$0.36 and the consensus revenue estimate is $54.77M (+8.5% Y/Y).

More on Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript
Vanda pharmaceuticals outlines $210M-$250M revenue target for 2025 amid product launches
Seeking Alpha’s Quant Rating on Vanda Pharmaceuticals
Historical earnings data for Vanda Pharmaceuticals
Financial information for Vanda Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。